We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
-1.85%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$59.6B
AUM Growth
+$306M
Cap. Flow
+$3.25B
Cap. Flow %
5.45%
Top 10 Hldgs %
34.29%
Holding
910
New
50
Increased
586
Reduced
175
Closed
66

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$2.14B
2
SUNB
Sunbelt Rentals Holdings
SUNB
+$96.9M
3
NVDA icon
NVIDIA
NVDA
+$86.8M
4
MSFT icon
Microsoft
MSFT
+$86.3M
5
KO icon
Coca-Cola
KO
+$75M

Top Sells

Rank Stock Value
1
D icon
Dominion Energy
D
+$90.4M
2
CRH icon
CRH
CRH
+$79.8M
3
MCO icon
Moody's
MCO
+$63.3M
4
PG icon
Procter & Gamble
PG
+$61.9M
5
TSM icon
TSMC
TSM
+$56.8M

Sector Composition

Rank Sector Weight
1 Technology 30.72%
2 Financials 12.76%
3 Healthcare 12.55%
4 Communication Services 9.75%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CL icon
51
Colgate-Palmolive
CL
$73.1B
$208M 0.35%
2,443,822
+244,758
+11% +$21.8M
ADI icon
52
Analog Devices
ADI
$183B
$200M 0.34%
627,877
-48,564
-7% -$15.5M
RY icon
53
Royal Bank of Canada
RY
$293B
$196M 0.33%
1,215,703
+33,921
+3% +$5.68M
IBM icon
54
IBM
IBM
$203B
$194M 0.33%
801,600
+22,949
+3% +$6.21M
MCD icon
55
McDonald's
MCD
$189B
$192M 0.32%
619,161
+18,367
+3% +$5.85M
NXPI icon
56
NXP Semiconductors
NXPI
$68.5B
$190M 0.32%
963,297
+26,240
+3% +$5.81M
TMO icon
57
Thermo Fisher Scientific
TMO
$197B
$189M 0.32%
384,002
-22,163
-5% -$12M
C icon
58
Citigroup
C
$217B
$186M 0.31%
1,636,616
+46,255
+3% +$5.27M
VZ icon
59
Verizon
VZ
$182B
$185M 0.31%
3,679,606
+89,308
+2% +$4.14M
T icon
60
AT&T
T
$152B
$180M 0.3%
6,193,614
+177,707
+3% +$4.75M
MS icon
61
Morgan Stanley
MS
$332B
$179M 0.3%
1,085,430
+29,028
+3% +$5.03M
ADP icon
62
Automatic Data Processing
ADP
$102B
$176M 0.29%
864,393
-44,490
-5% -$10.2M
TSM icon
63
TSMC
TSM
$2.09T
$170M 0.29%
503,737
-165,070
-25% -$56.8M
KLAC icon
64
KLA
KLAC
$274B
$169M 0.28%
1,144,560
+32,650
+3% +$4.78M
INTC icon
65
Intel
INTC
$496B
$167M 0.28%
3,773,574
+109,276
+3% +$5.01M
GILD icon
66
Gilead Sciences
GILD
$166B
$164M 0.27%
1,174,576
+17,838
+2% +$2.5M
AMGN icon
67
Amgen
AMGN
$197B
$163M 0.27%
464,183
+13,282
+3% +$4.73M
SPGI icon
68
S&P Global
SPGI
$134B
$160M 0.27%
376,871
-7,836
-2% -$3.64M
TXN icon
69
Texas Instruments
TXN
$262B
$155M 0.26%
796,422
+22,737
+3% +$4.6M
CRM icon
70
Salesforce
CRM
$143B
$154M 0.26%
827,538
+23,214
+3% +$4.81M
TMUS icon
71
T-Mobile US
TMUS
$210B
$152M 0.26%
724,936
+70,190
+11% +$14.4M
DIS icon
72
Walt Disney
DIS
$168B
$150M 0.25%
1,560,167
+43,990
+3% +$4.65M
AXP icon
73
American Express
AXP
$241B
$147M 0.25%
487,503
-31,657
-6% -$10.6M
PEG icon
74
Public Service Enterprise Group
PEG
$38.7B
$146M 0.25%
1,809,071
+617,947
+52% +$50.7M
XYL icon
75
Xylem
XYL
$28.7B
$142M 0.24%
1,188,344
+447,031
+60% +$58.6M

Similar funds

Aviva's Q1 2026 Portfolio in Review

As of Q1 2026, Aviva held 910 positions worth $59.6B, up 0.52% from $59.3B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Aviva deployed $3.25B of net new capital in Q1 2026, opening 50 new positions and adding to 586 existing holdings. Its largest new stake was AstraZeneca: 11,087,661 shares worth $2.15B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Dominion Energy, an estimated $90.4M trimmed.

  • Aviva's largest Q1 2026 buy was AstraZeneca: 11,087,661 shares worth $2.15B.
  • Aviva added most to NVIDIA in Q1 2026, an estimated $86.8M increase.
  • Aviva's biggest Q1 2026 reduction was Dominion Energy, cutting an estimated $90.4M.
  • Aviva fully exited Alibaba in Q1 2026, selling an estimated $51M.
  • Aviva's ten largest holdings make up 34% of its $59.6B portfolio in Q1 2026.
  • Aviva opened 50 new positions and closed 66 in Q1 2026.
  • Aviva's portfolio value rose 0.52% quarter-over-quarter to $59.6B.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.